Skip to main content

Advertisement

SpringerLink
Log in

Dipeptidyl peptidase-4 inhibitors are associated with improved left ventricular diastolic function after acute myocardial infarction in diabetic patients

  • Short Communication
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Dipeptidyl peptidase-4 (DPP4) is an integral membrane glycoprotein that modulates the pathological state of diabetes mellitus (DM), and DPP4 inhibitors are a new class of anti-type-2 DM drugs. Recent preclinical studies have associated DPP4 inhibition with improved myocardial systolic and diastolic function. Based on preclinical findings, we investigated associations between the administration of DPP4 inhibitors and cardiac function after acute myocardial infarction (AMI) in a clinical setting. We enrolled 34 patients with diabetes who were treated for acute myocardial infarction at our hospital between January 2010 and December 2012. We retrospectively compared changes in cardiac parameters determined by trans-thoracic echocardiography between patients treated with (DPP4-I group; n = 13) or without (non-DPP4-I group; n = 21) a DPP4 inhibitor during follow-up. The values of E/e′ and of e′/a′ significantly decreased and increased, respectively, in the DPP4-I, compared with the non-DPP4-I group (−2.53 ± 5.53 vs. 2.58 ± 5.68, p = 0.038 and 0.08 ± 0.23 vs. −0.12 ± 0.21, p = 0.036, respectively). We concluded that DPP4 inhibitors could improve E/e′ and e′/a′ in patients with DM and AMI and thus might be effective for treating left ventricular diastolic failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mentlein R (1999) Dipeptidyl-peptidase IV (CD26)–role in the inactivation of regulatory peptides. Regul Pept 85(1):9–24

    Article  CAS  PubMed  Google Scholar 

  2. Yu DM, Yao TW, Chowdhury S, Nadvi NA, Osborne B, Church WB, McCaughan GW, Gorrell MD (2010) The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J 277(5):1126–1144

    Article  CAS  PubMed  Google Scholar 

  3. Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368(9548):1696–1705

    Article  CAS  PubMed  Google Scholar 

  4. Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R, Fischer R, Krieg L, Hirsch E, Huber B, Nathan P, Israel L, Imhof A, Herbach N, Assmann G, Wanke R, Mueller-Hoecker J, Steinbeck G, Franz WM (2009) Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 4(4):313–323

    Article  CAS  PubMed  Google Scholar 

  5. Sauve M, Ban K, Momen MA, Zhou YQ, Henkelman RM, Husain M, Drucker DJ (2010) Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice. Diabetes 59(4):1063–1073

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Shigeta T, Aoyama M, Bando YK, Monji A, Mitsui T, Takatsu M, Cheng XW, Okumura T, Hirashiki A, Nagata K, Murohara T (2012) Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions. Circulation 126(15):1838–1851

    Article  CAS  PubMed  Google Scholar 

  7. Connelly KA, Zhang Y, Advani A, Advani SL, Thai K, Yuen DA, Gilbert RE (2013) DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetes. Cardiovasc Ther 31(5):259–267

    Article  CAS  PubMed  Google Scholar 

  8. Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I (2013) Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 369(14):1317–1326

    Article  CAS  PubMed  Google Scholar 

  9. White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F (2013) Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 369(14):1327–1335

    Article  CAS  PubMed  Google Scholar 

  10. Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M (2008) Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation 117(18):2340–2350

    Article  CAS  PubMed  Google Scholar 

  11. Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ (2009) GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes 58(4):975–983

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS (2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362(9385):697–703

    Article  CAS  PubMed  Google Scholar 

  13. Takahashi M (2010) Role of the SDF-1/CXCR4 system in myocardial infarction. Circ J 74(3):418–423

    Article  CAS  PubMed  Google Scholar 

  14. Segal MS, Shah R, Afzal A, Perrault CM, Chang K, Schuler A, Beem E, Shaw LC, Li Calzi S, Harrison JK, Tran-Son-Tay R, Grant MB (2006) Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 55(1):102–109

    Article  CAS  PubMed  Google Scholar 

  15. Zhang D, Huang W, Dai B, Zhao T, Ashraf A, Millard RW, Ashraf M, Wang Y (2010) Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts. Am J Physiol Heart Circ Physiol 299(5):H1339–H1347

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the staff at our hospital for assistance with sample collection and appreciate the patients for participating in the study.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya Ward, Saitama, Saitama, 330-8503, Japan

    Takayuki Fujiwara, Tomohiro Nakamura, Kenichi Sakakura, Hiroshi Wada, Kenshiro Arao, Takuji Katayama, Hiroshi Funayama, Yoshitaka Sugawara, Takeshi Mitsuhashi & Shin-ichi Momomura

  2. Department of Endocrinology and Metabolism, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya Ward, Saitama, 330-8503, Saitama, Japan

    Masashi Yoshida & Masafumi Kakei

  3. Department of Cardiovascular Medicine, Kitasato University, 1-15-1 Kitasato, Minami Ward, Sagamihara, 252-0375, Kanagawa, Japan

    Junya Ako

Authors
  1. Takayuki Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masashi Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomohiro Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenichi Sakakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroshi Wada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenshiro Arao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takuji Katayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroshi Funayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yoshitaka Sugawara
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Takeshi Mitsuhashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Masafumi Kakei
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shin-ichi Momomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Junya Ako
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shin-ichi Momomura.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fujiwara, T., Yoshida, M., Nakamura, T. et al. Dipeptidyl peptidase-4 inhibitors are associated with improved left ventricular diastolic function after acute myocardial infarction in diabetic patients. Heart Vessels 30, 696–701 (2015). https://doi.org/10.1007/s00380-014-0509-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-014-0509-4

Keywords

Search

Navigation